×
Back to Agenda
Defining an Inclusive Clinical Trials Approach in Europe
Session Chair(s)
Ambily Banerjee, PHD
Senior Director/Head of Diversity in Clinical Trials, Johnson and Johnson Innovative Medicine, United Kingdom
This forum will address industry challenges in the recruitment and retention of underserved populations in clinical research, and explores how regulators, physicians, sponsors and others can work together to develop solutions to tackle health equity.
Learning Objective : Identify a proposal for addressing underrepresentation of underserved populations in Europe; Describe regulatory and industry perspectives in addressing recruitment and retention challenges for multi-regional clinical trials; Discuss best practices that can help shape inclusivity of clinical trials across borders.
Speaker(s)
The EU Perspective and the Role of ACT EU
Head of Clinical Trials Transformation Workstream, European Medicines Agency, Netherlands
Evolving FDA Perspective Based on Learningd from DAP Submissions on What Diversity Looks Like
Vice President, Regulatory Policy, BridgeBio, United States
Industry Perspective of Community Engagement in Europe: A Case Study
Executive Director, Global Head Diversity and Inclusion in Clinical Trials , Sanofi, United States
CT Network One-Pager v2
Executive Director, Patient Focused Medicines Development (PFMD), The Synergist, Belgium
Have an account?